Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon contact icon menu icon
Medicilon Logo
|
search icon close search icon contact icon menu icon
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Join Medicilon at 2024 BioSpark Annual Conference

2024-08-16
|
Page View:

1.png

2024 BioSpark Annual Conference

Braving through the Winter of Biotech

BioSpark will host the 2024 Annual Conference on Saturday, September 14 at Cambridge, MA. The conference theme this year is “Braving through the Winter of Biotech”, and will bring together professionals from the biotech industry to discuss the latest trends and innovations. Whether you're a seasoned expert or just starting out in the field, this event is perfect for anyone looking to stay ahead in the world of biotechnology.

FEATURE SESSIONS:

❖BioSpark Annual Biotech News Review

❖Cancer Immunotherapy, Immunology and Inflammatory Diseases

❖RNA Targeting Drug Discovery

❖Precision Medicine in Oncology and CNS Diseases

❖AI in Drug Discovery and Development

❖Cross-Boarder BD in 2024: What is the Next Wave?

Medicilon is excited to attend and exhibit at the conference. Dr. Qingcong Lin, president of Medicilon USA Corp. will give a presentation "Medicilon Drug Discovery Cutting Edge Technology Platform Introduction" at 12:15-12:30 pm local time. Dr. Lin brings nearly 40 years of experience in pharmaceutical R&D, making significant contributions to both academia and the global industry. Medicilon team will be present throughout the event. Please stop by our booth and chat how our services and capabilities would support your research needs and expedite your drug discovery and development programs.      

Date: Saturday, September 14, 9:00AM - 5:40PM EST

Location: Stata Center, 32 Vassar St, Cambridge, MA 02139

200.png

Agenda议程1.png

议程2.png

议程3.png

Meet with Medicilon
Subject丨2024 BioSpark Annual Conference

Share:
Return
Relevant newsOnline registration
Company*
Name*
Work Email*
Title*
Verification Code*
Click to switch
Relevant newsRelevant news